Category | Variable |
---|---|
Medication dataa Long-term medication (antipsychotic drugs) | • Registered trade name or agent |
• Dosage form and regimen | |
• Daily dose | |
• Prescription period | |
• Prescribing physician | |
• Indication | |
PRN medication (antipsychotic drugs) | • Registered trade name or agent |
• Dosage form | |
• Number of received partial dose | |
• Suggested maximum dose | |
• Prescription period | |
• Prescribing physician | |
• Case of need | |
Further current long-term and PRN medication | • Registered trade name or agent |
• Dose | |
• Regimen | |
Medical carea | • Psychopathological reports |
• Number of physician contacts (GP, neurologist, psychiatrist, and geriatrician) over the last three months and date of the last visit | |
• Body weight: current and three months before | |
• Intolerance of drugs | |
Neuropsychiatric symptomsa (over the last 2 weeks) | • Delusion |
• Hallucination | |
• Aggression | |
• Verbal abnormality | |
• Agitation | |
• Depression | |
• Anxiety | |
• Apathy | |
• Disinhibition | |
• Irritability | |
• Sleep disturbances | |
Potential adverse effects of antipsychotic drugsa (over the last 2 weeks) | • Pain |
• Aberrant motor behaviour | |
• Malposition | |
• Repetitive behaviour | |
• Tremor | |
• Somnolence | |
• Delirium | |
Socio-demographic and clinical datab | • Age |
• Gender | |
• Body height | |
• Relevant clinical diagnoses | |
• Falls |